NEWS COMMENTARY

U.S. FDA collaborates with Apple, Biofourmis, Biovotion, Yale University, and Mayo Clinic to study digital endpoints of heart disease

Published:
July 19, 2019
Coverage:
Digital Transformation More...
Activities:
Partnership
by Nardev Ramanathan
Very important

This study signals the emergence of a new generation of clinical trials that takes advantage of portable medical-grade wearables and digital therapeutic platforms for clinically defined endpoints. Unlike the Apple Heart Study, this partnership here is unique in having the involvement of a major healthcare regulator and different companies, allowing a broader assessment across devices and analytic platforms. In addition to examining "hard" outcomes like mortality and hospitalization rates, digital health tools also provide insights into patient satisfaction and well-being. Clients should note the trend toward patient-centric endpoints and engage in opportunities that place importance on the patient experience. 

For the original news article, click here .


Further Reading

Mental health apps demonstrate what works in the digital transformation of healthcare

Analyst Insight | December 05, 2019

As the digital transformation of healthcare is well underway, mental health is likewise being digitally transformed by new digital tools and analytics. Digital tools address the major challenges in mental health: high costs, provider shortages, and the stigma of mental health treatment during a time... Not part of subscription

Caption Health receives U.S. FDA de novo clearance for AI-guided ultrasound

News Commentary | February 11, 2020

Caption Health's ultrasound device, intended for use in cardiac ultrasonography, uses AI to guide the user through the process of taking optimal images. The value proposition of this device is to democritize ultrasound technology within the medical community, allowing patients access to a cardiac ... Not part of subscription

The future of telehealth in the wake of COVID-19

Analyst Insight | May 06, 2020

With the lockdowns brought on by COVID‑19, telehealth is seeing a surge in adoption. Due to the virus, the regulatory and infrastructure hurdles that have prevented widespread adoption have largely been cleared – making 20 years' worth of technology suddenly available in just a handful of days. ... Not part of subscription